What diagnostic investigations are standard of care for a patient with confirmed or suspected dengue who presents with abdominal pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Standard Diagnostic Workup for Dengue Patients with Abdominal Pain

For dengue patients presenting with abdominal pain, obtain a complete blood count with differential, liver enzymes (AST/ALT), coagulation studies (PT/aPTT), and abdominal ultrasound to assess for warning signs of severe dengue including plasma leakage, hemorrhage, and organ involvement.

Algorithmic Approach to Diagnostics

Immediate Laboratory Testing

When a dengue patient develops abdominal pain, this represents a warning sign that mandates specific laboratory monitoring to prevent progression to severe dengue 1:

Essential hematologic parameters:

  • Complete blood count - Monitor for rising hematocrit (indicating plasma leakage) and falling platelet count. Platelet count <50,000/μL with rising hematocrit signals impending shock 2
  • Serial hematocrit measurements - A 10-20% increase indicates significant plasma leakage
  • White blood cell count - Leukopenia or neutropenia supports dengue diagnosis and correlates with severity 2

Coagulation assessment:

  • Prothrombin time (PT) and activated partial thromboplastin time (aPTT) - Prolonged aPTT (OR = 5.815) and PT (OR = 2.432) are significantly associated with need for platelet transfusion and severe disease 2
  • These parameters help distinguish dengue-related coagulopathy from surgical causes of abdominal pain

Hepatic function:

  • AST and ALT levels - Transaminitis is common in dengue; an AST²/ALT ratio (OR = 2.431) correlates with disease severity 2
  • Elevated liver enzymes help differentiate dengue from acute appendicitis or cholecystitis 3, 4

Imaging Studies

Abdominal ultrasound is the imaging modality of choice and should be performed when dengue patients present with abdominal pain 5:

Key ultrasound findings to assess:

  • Gallbladder wall thickening (OR = 4.212) - Highly associated with severe dengue and correlates with abdominal pain 2, 5
  • Ascites/free fluid (OR = 5.059) - Indicates plasma leakage, a hallmark of progression to severe dengue 2, 5
  • Pleural effusion (OR = 2.917) - Another marker of vascular permeability 2
  • Hepatomegaly and splenomegaly - Positively associated with abdominal pain in dengue 5
  • Gallbladder contractility/motor function - Reduced emptying fraction correlates with abdominal pain and disease severity 5

Ultrasound findings of free fluid around the appendix may mimic appendicitis but actually represent plasma leakage from dengue 4.

Virologic Confirmation

If dengue diagnosis is not yet confirmed, perform appropriate testing based on symptom duration 1:

For patients ≤7 days from symptom onset:

  • Dengue NAAT (PCR) on serum - preferred diagnostic method
  • NS1 antigen testing - alternative to NAAT with similar sensitivity 1

For patients >7 days from symptom onset:

  • Dengue IgM antibody testing on serum
  • Consider Zika virus testing if in co-endemic area 1

Critical Clinical Pitfalls

Avoiding Unnecessary Surgery

The most dangerous pitfall is misdiagnosing dengue as a surgical abdomen 3, 4. Dengue commonly mimics:

  • Acute appendicitis (right iliac fossa tenderness, rebound tenderness)
  • Acute cholecystitis (right upper quadrant pain, gallbladder wall thickening)
  • Pancreatitis
  • Non-specific peritonitis

Key differentiating features:

  • Thrombocytopenia and leukopenia typically appear by day 3-4 of illness in dengue 4
  • C-reactive protein remains low (<12 mg/L) in dengue versus elevated in bacterial infections 4
  • Abdominal symptoms in dengue typically resolve within 1-2 days with supportive care 4
  • Surgery in thrombocytopenic dengue patients carries significant morbidity and mortality risk 3

Timing Considerations

Obtain complete laboratory workup on day 3-4 of illness when hematologic changes become most apparent 4. Earlier testing may show equivocal results, creating diagnostic uncertainty 3.

Monitoring for Progression

Abdominal pain in dengue signals the critical phase (typically days 3-7 of illness) when plasma leakage occurs 1. Serial monitoring every 4-6 hours of hematocrit, platelet count, and vital signs is essential during this period.

Implementation Notes

The evidence strongly supports that vigilant clinical suspicion combined with early dengue serological assessment is advisable in equivocal cases of acute abdomen with fever in dengue-endemic areas 3. This approach prevents unnecessary surgical morbidity while ensuring appropriate monitoring for severe dengue complications including shock and hemorrhage 1.

Contrast-enhanced CT may be considered if ultrasound is inconclusive and surgical pathology remains a concern, but recognize that hemoperitoneum in dengue can occur spontaneously without identifiable bleeding source and may be managed conservatively 6.

References

Research

Dengue fever may mislead the surgeons when it presents as an acute abdomen.

Asian Pacific journal of tropical medicine, 2017

Research

Dengue fever mimicking acute appendicitis.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007

Research

Ultrasound Assessment of Hepatobiliary and Splenic Changes in Patients With Dengue and Warning Signs During the Acute and Recovery Phases.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.